U.S. flag

An official website of the United States government

NC_000002.11:g.(26726714_26739285)_(26741978_26750699)del AND Nonsyndromic genetic hearing loss

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 19, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003155828.1

Allele description [Variation Report for NC_000002.11:g.(26726714_26739285)_(26741978_26750699)del]

NC_000002.11:g.(26726714_26739285)_(26741978_26750699)del

Gene:
OTOF:otoferlin [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
2p23.3
Genomic location:
Chr2: 26726714 - 26750699 (on Assembly GRCh37)
Preferred name:
NC_000002.11:g.(26726714_26739285)_(26741978_26750699)del
HGVS:
NC_000002.11:g.(26726714_26739285)_(26741978_26750699)del

Condition(s)

Name:
Nonsyndromic genetic hearing loss
Synonyms:
Nonsyndromic hearing loss and deafness; Non-syndromic genetic deafness; Nonsyndromic genetic deafness
Identifiers:
MONDO: MONDO:0019497; MedGen: C5680182; Orphanet: 87884

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003844985Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Feb 19, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003844985.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 4-5 in the OTOF gene. A presumed nomenclature of c.(227+1_228-1)_(509+1_510-1)del has been designated for the purposes of this classification. Although exact breakpoints of this deletion are not known, it is expected to result in a large in-frame deletion change in the OTOF gene, and affects the first C2 domain of the encoded protein (IPR000008). The variant was absent in 21694 control chromosomes in gnomAD database, structural variants data set. To our knowledge, no occurrence of c.(227+1_228-1)_(509+1_510-1)del in individuals affected with Nonsyndromic Hearing Loss And Deafness, Type 9 and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Missense variants in the overlapping deleted region (p.R82H, p.R69W) are reported in patients affected with hearing loss (PMID 31152317, PMID 34837038). Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023